Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Amgen Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Amgen Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Amgen Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Amgen Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Amgen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Amgen Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Gamida Cell Raises US$10 Million In Series E Financing 12
Partnerships 14
Biocartis Enters into Co-Development Agreement with Amgen 14
Adaptive Biotechnologies Enters into Agreement with Amgen for Multiple Myeloma 15
Adaptive Biotech Enters into Agreement with Amgen 16
Biocartis Partners with Amgen 17
Exosome Diagnostics Enters into Agreement with Amgen 18
Flatiron Health Partners with Amgen 19
Biocartis Enters into Agreement with Amgen 20
Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 21
Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 22
Illumina Enters Into Co-Development Agreement With Amgen For Oncology Companion Diagnostic Test 23
KineMed Enters Into Co-Development Agreement With Amgen For Kinetic Biomarkers Of Brain Proteinopathies 24
Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 25
Dako Enters Into Co-Development Agreement With Amgen 26
Dako Enters Into Co-Development Agreement With Amgen 27
Warnex Medical Labs Enters Into Distribution Agreement With deCODE genetics 28
Merger 29
AstraZeneca Rumored To Merge With Amgen 29
Amgen Enters into Licensing Agreement with Unilife 30
Atara Biotherapeutics Enters Into Licensing Agreement with Amgen 31
Debt Offering 32
Amgen Raises USD1 Billion in Public Offering of 3.2% Notes Due 2027 32
Unilife Raises USD30 Million in First Tranche of Private Placement of 6% Senior Secured Convertible Notes Due 2023 34
Amgen Raises USD1.4 Billion in Public Offering of Notes Due 2019 36
Amgen Raises USD1.4 Billion in Public Offering of Notes Due 2024 38
Amgen Raises USD600 Million in Public Offering of Floating Notes Due 2017 40
Amgen Raises USD250 Million in Public Offering of Floating Notes Due 2019 42
Amgen Raises USD850 Million in Public Offering of Notes Due 2017 44
Acquisition 46
Amgen Completes Acquisition Of Decode Genetics, Human Genetics Company, For US$401 Million 46
Amgen Inc – Key Competitors 48
Amgen Inc – Key Employees 49
Amgen Inc – Locations And Subsidiaries 51
Head Office 51
Other Locations & Subsidiaries 51
Joint Venture 57
Recent Developments 58
Strategy And Business Planning 58
Jun 02, 2017: Amgen Showcases A Legacy Of Science, Innovation And Collaboration In Cambridge 58
Financial Announcements 59
Oct 25, 2017: Amgen Reports Third Quarter 2017 Financial Results 59
Jul 25, 2017: Amgen Reports Second Quarter 2017 Financial Results 61
Apr 26, 2017: Amgen Reports First Quarter 2017 Financial Results 63
Feb 02, 2017: Amgen Reports Fourth Quarter And Full Year 2016 Financial Results 66
Oct 27, 2016: Amgen Reports Third Quarter 2016 Financial Results 69
Jul 27, 2016: Amgen Reports Second Quarter 2016 Financial Results 72
Apr 28, 2016: Amgen’s First Quarter 2016 Revenues Increased 10 Percent To $5.5 Billion And Adjusted Earnings Per Share (EPS) Increased 17 Percent To $2.90 75
Jan 28, 2016: Amgen’s 2015 Revenues Increased 8 Percent To $21.7 Billion And Adjusted Earnings Per Share Increased 19 Percent To $10.38 77
Corporate Communications 79
Dec 11, 2017: Amgen Foundation Pledges Up To $500,000 In Relief To Victims Of The Southern California Wildfires 79
Oct 24, 2017: Amgen Announces Appointment Of Wanda M. Austin To Board Of Directors 80
Sep 22, 2017: Amgen Foundation Pledges Up To $5 Million To Hurricane Maria Relief Efforts 81
Feb 03, 2017: Amgen Announces Appointment of Charles M. Holley Jr. to Board of Directors 82
Nov 02, 2016: Amgen Appoints Lori Johnston As Senior Vice President, Human Resources 83
Oct 14, 2016: Amgen Announces Appointment Of Ellen J. Kullman To Board Of Directors 84
Jun 17, 2016: Amgen Appoints Esteban Santos Executive Vice President, Operations 85
Legal and Regulatory 86
Jul 20, 2016: Amgen Announces Settlement Of Securities Litigation 86
Government and Public Interest 87
Jul 11, 2017: Amgen And QB3@953 Announce Winners Of The Amgen Golden Ticket 87
Product News 88
Oct 17, 2016: West to Showcase Expertise in Injectable Drug Containment and Delivery at PDA Universe of Pre-filled Syringes & Injection Devices 88
Other Significant Developments 90
Sep 25, 2017: Amgen Provides Update On Hurricane Maria 90
Mar 29, 2017: Amgen Enters into Agreement with Inovalon and Avalere to Engage Value-based Contracting Opportunities 91
Jan 09, 2017: DaVita Enters Into New Sourcing and Supply Agreement with Amgen and Initiates 2017 Kidney Care Guidance 92
Feb 12, 2016: West’s Daikyo Crystal Zenith Cyclic Olefin Polymer Selected by Amgen 93
Appendix 94
Methodology 94
About GlobalData 94
Contact Us 94
Disclaimer 94
Amgen Inc, Medical Equipment, Key Facts, 2016 2
Amgen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Amgen Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Amgen Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Amgen Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Amgen Inc, Deals By Market, 2011 to YTD 2017 9
Amgen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Gamida Cell Raises US$10 Million In Series E Financing 12
Biocartis Enters into Co-Development Agreement with Amgen 14
Adaptive Biotechnologies Enters into Agreement with Amgen for Multiple Myeloma 15
Adaptive Biotech Enters into Agreement with Amgen 16
Biocartis Partners with Amgen 17
Exosome Diagnostics Enters into Agreement with Amgen 18
Flatiron Health Partners with Amgen 19
Biocartis Enters into Agreement with Amgen 20
Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 21
Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 22
Illumina Enters Into Co-Development Agreement With Amgen For Oncology Companion Diagnostic Test 23
KineMed Enters Into Co-Development Agreement With Amgen For Kinetic Biomarkers Of Brain Proteinopathies 24
Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 25
Dako Enters Into Co-Development Agreement With Amgen 26
Dako Enters Into Co-Development Agreement With Amgen 27
Warnex Medical Labs Enters Into Distribution Agreement With deCODE genetics 28
AstraZeneca Rumored To Merge With Amgen 29
Amgen Enters into Licensing Agreement with Unilife 30
Atara Biotherapeutics Enters Into Licensing Agreement with Amgen 31
Amgen Raises USD1 Billion in Public Offering of 3.2% Notes Due 2027 32
Unilife Raises USD30 Million in First Tranche of Private Placement of 6% Senior Secured Convertible Notes Due 2023 34
Amgen Raises USD1.4 Billion in Public Offering of Notes Due 2019 36
Amgen Raises USD1.4 Billion in Public Offering of Notes Due 2024 38
Amgen Raises USD600 Million in Public Offering of Floating Notes Due 2017 40
Amgen Raises USD250 Million in Public Offering of Floating Notes Due 2019 42
Amgen Raises USD850 Million in Public Offering of Notes Due 2017 44
Amgen Completes Acquisition Of Decode Genetics, Human Genetics Company, For US$401 Million 46
Amgen Inc, Key Competitors 48
Amgen Inc, Key Employees 49
Amgen Inc, Other Locations 51
Amgen Inc, Subsidiaries 53
Amgen Inc, Joint Venture 57